{
Shanghai Junshi Biosciences Co., Ltd.

Companies

}

Dr Reddy's launches Toripalimab for nasopharyngeal carcinoma in India

Dr Reddy's Laboratories has launched Toripalimab, the first immunooncology drug approved for nasopharyngeal carcinoma, in India. This follows a licensing agreement with Shanghai Junshi Biosciences, granting exclusive rights to market the drug in 21 countries, including India. With this launch, India becomes the third country to access Toripalimab, marketed as Zytorvi, addressing a significant need for advanced NPC treatment.
Moneycontrol
Dr Reddy's Laboratories Ltd Shanghai Junshi Biosciences Co., Ltd. IND CHN USA M. V. Ramana Show more
Healthcare, Press Release
09:46 29.11.2024
Trending
Subcategory:
Cryptocurrency Markets Cryptocurrency Trends Stock Market Updates Market Sentiment Analysis Decentralized Finance (DeFi) Innovations Market Analysis and Predictions Hedge Funds & Private Equity Central Bank Actions Tokenomics and Crypto Economics Banking Regulations Cryptocurrency Regulations Anti-Money Laundering (AML) Regulations Cryptocurrency & Blockchain Regulations Employment Reports Inflation Rates & CPI Data GDP Growth & Recession Forecasts Community Building in Blockchain Gaming ESG & Sustainable Finance Regulations Market Updates Mergers & Acquisitions
Countries:
USA CHE KEN DEU BRA PHL CAN PRK IND JPN KOR ARE KAZ FRA SGP KHM
Companies:
Apple Inc. Santiment Network Token USD Ripples USD International Monetary Fund FUND Notcoin USD BTG Pactual Chile S.A. Administradora General De Fondos - Liquidez Alternativa Fund Julius Bär Gruppe AG VanEck Bitcoin ETF Bitwise Bitcoin ETF Bitcoin USD Cantilan Bank Inc. Ethereum USD Grayscale Bitcoin Trust ETF Ripple USD USD RENDER Arweave AUD Uniswap KRW Solana USD TRON USD WazirX USD
Currencies:
United States Dollar Philippine Peso Malagasy Ariary Japanese Yen Euro Singapore Dollar
People:
Ali Martinez Donald Trump Javon Marks Shytoshi Kusama John Mbadi Frank Schäffler Patrick Hansen Christian Lindner Hunter Horsley Shayan Yo Alexander Busch André Esteves Matthew Sigel Letitia James Peter Brandt Dmx Ryan Selkis Eric Turner Brad Garlinghouse Chris Larsen

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.